Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis

Int J Dermatol. 2022 May;61(5):e173-e174. doi: 10.1111/ijd.16009. Epub 2021 Nov 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Chronic Disease
  • Chronic Urticaria* / complications
  • Chronic Urticaria* / drug therapy
  • Dermatitis, Atopic* / complications
  • Dermatitis, Atopic* / drug therapy
  • Female
  • Humans
  • Middle Aged
  • Omalizumab / therapeutic use
  • Treatment Outcome
  • Urticaria* / complications
  • Urticaria* / drug therapy

Substances

  • Anti-Allergic Agents
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • dupilumab